Professor Antonio Ceriello Joins Mendor as Medical Director

HELSINKI, March 16, 2015 /PRNewswire/ --

Mendor, a leading diabetes management company, is happy to announce that a respected diabetes researcher, medical doctor and Professor, Antonio Ceriello will join Mendor as a Medical Director.

     (Logo: http://photos.prnewswire.com/prnh/20150316/735259 )

Professor Ceriello is Head of the Research Department on Diabetes and CVD at the Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.

Professor Ceriello has published widely in the area of diabetes with over 350 original papers and several book chapters. Prof. Ceriello has been consultant of the National Institutes of Health, U.S.A. for the program of the research 2003-2005, related to cardiovascular disease and type 1 diabetes, and member of the writing committee of the American Heart Association for "Acute Hyperglycemia and Acute Coronary Syndromes".

Professor Ceriello has chaired the International Diabetes Federation committee for the development and also for the 2011 update of "Guideline for Management of Postmeal Glucose" and, currently, is the President of the European Association for the Study of Diabetes Study Group on "Diabetes and Cardiovascular Diseases". He also served as Review of the 2012 "European Guidelines on Cardiovascular Disease Prevention in Clinical Practice" and for the 2013 "European Society of Cardiology guidelines on diabetes, pre-diabetes, and cardiovascular diseases".

From 2009 to 2012 he has been member of the Board of IDF Europe. He also served as Associate Editor of "Diabetes Care" from 2003 to 2011, and is currently serving as Associate Editor of "Diabetic Medicine" and as member of the Editorial Board of "Diabetes Research and Clinical Practice" and "Diabetes and Vascular Disease Research". Prof. Ceriello is the winner in 1984 of the "Italian Annual Award for Young Researcher", in 1990 of the "National Award for Research on the Pathophysiology of Diabetic Complications", in 1998 of the "National Award Italian Society of Diabetology" and in 2004 of the "Camillo Golgi Prize" of the EASD.

Prof. Ceriello comments regarding Mendor and the opportunity to improve diabetes care globally:

"Mendor is one of the most advanced Company in the field of mHealth technology, offering very advanced solutions for the management of diabetes. These Solutions can make a difference for health care professionals and people with diabetes in managing this challenging disease. I am very glad to offer my experience to such a dynamic company in order to further progress to find even better solutions enabling improvement, worldwide, of the life of people with diabetes."